Kamau Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA · Founded 2023 · CIK 0002071165 · Biotech · Private
High-efficiency targeted gene integration platform for gene correction therapeutics
kamautx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $5.0M
- 1 Form D · Jun 2025
- 16 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,999,997 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2503 | Exciva | — | — |
| 2504 | GYRE THERAPEUTICS, INC. | — | $5.0M |
| 2505 | VIVOVERSE, LLC | — | — |
| 2506 | Kamau Therapeutics, Inc. | — | $5.0M |
| 2507 | CONFLUENCE LIFE SCIENCES, INC. | — | $5.7M |
| 2508 | Panorama Medicine Inc | — | $4.7M |
| 2509 | GENEDIT INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Valentin BarsanDirector · Executive Officer
- Ness BerminghamDirector
- Raymond KelleherDirector
- Matthew PorteusDirector · Executive Officer
Patents
- Improved Peptide Inhibitors Of P53 Binding Protein 53BP1application
- Methods For Genotyping Gene-edited Hematopoietic Stem Cellsapplication
- Methods To Genetically Engineer Hematopoietic Stem And Progenitor Cells For Red Cell Specific Expression Of Therapeutic Proteinsapplication
- Methods And Compositions For Production Of Genetically Modified Primary Cellsapplication
- Methods And Compositions For Production Of Genetically Modified Primary Cellsapplication
- Improved Peptide Inhibitors Of P53 Binding Protein 53BP1application
- Methods For Clinical-scale Production Of Genetically Modified Primary Cellsapplication
- Methods For Genotyping Gene-edited Hematopoietic Stem Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.